Media Highlights

Media Highlights

New antibody combination shows ‘surprising’ results in high-risk follicular lymphoma trial

December 11, 2023

Dr. Juan Pablo Alderuccio is quoted extensively and identified as the lead author of a study presented at ASH 2023 on pairing the antibodies loncastuximab and rituximab for treatment of patients with follicular lymphoma.

Read the Full article

Tags:   Sylvester Comprehensive Cancer Center